Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell-induced oxidative stress

International Journal of Cancer

Volumn 123, Issue 11, 2008, Pages 2503-2511

  Tsuchiya, Masato ^a,b   Kono, Hiroshi ^b   Matsuda, Masanori ^b   Fujii, Hideki ^b   Rusyn, Ivan ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Hepatocellular carcinoma; Intrahepatic recurrence free survival; Kupffer cell; TJ 48

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANGELICA ROOT; ANGELICA ROOT EXTRACT; ASTRAGALI RADIX EXTRACT; ATRACTYLODIS LANCEAE RHIZOMA EXTRACT; CINNAMOMI CORTEX EXTRACT; CNIDIUM RHIZOME EXTRACT; CYCLINE; DIETHYLNITROSAMINE; GINSENG EXTRACT; GLYCYRRHIZA EXTRACT; HOELEN EXTRACT; PAEONIA RADIX; PLANT EXTRACT; REHMANNIAE RADIX EXTRACT; SHI QUAN DA BU TANG; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADULT; ANGELICA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTRAGALI RADIX; ATRACTYLODIS LANCEAE RHIZOMA; CANCER GROWTH; CANCER INCIDENCE; CANCER RECURRENCE; CELL INFILTRATION; CELL ISOLATION; CELL PROLIFERATION; CINNAMON; CNIDIUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DISEASE FREE SURVIVAL; DNA DAMAGE; FEMALE; GINSENG; GLYCYRRHIZA; HEPATITIS B; HEPATITIS C; HOELEN; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; KUPFFER CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER PROTECTION; LIVER SURGERY; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; OXIDATIVE STRESS; PAEONIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REHMANNIA ROOT; RNA ISOLATION;

AGED; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CYTOPROTECTION; DIETHYLAMINES; DISEASE MODELS, ANIMAL; DISEASE-FREE SURVIVAL; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; KUPFFER CELLS; MALE; MICE; NEOPLASM RECURRENCE, LOCAL; OXIDATIVE STRESS;

EID: 57349182163     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23828     Document Type: Article

References (46)

1. Inoue H, Seitz HK. Viruses and alcohol in the pathogenesis of primary hepatic carcinoma. Eur J Cancer Prev 2001;10:107-10.
2. Kountouras J, Lygidakis NJ. New epidemiological data on liver oncogenesis. Hepatogastroenterology 2000;47:855-61.
3. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003;3:276-85.
4. Koike K, Miyoshi H. Oxidative stress and hepatitis C viral infection. Hepatol Res 2006;34:65-73.
5. De Maria N, Colantoni A, Fagiuoli S, Liu GJ, Rogers BK, Farinati F, Van Thiel DH, Floyd RA. Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med 1996;21:291-5.
6. Matsumoto K, Yoshimoto J, Sugo H, Kojima K, Futagawa S, Matsumoto T. Relationship between the histological degrees of hepatitis and the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis C. Hepatol Res 2002;23:196-201.
7. Jungst C, Cheng B, Gehrke R, Schmitz V, Nischalke HD, Ramakers J, Schramel P, Schirmacher P, Sauerbruch T, Caselmann WH. Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma. Hepatology 2004;39:1663-72.
8. Maki A, Kono H, Gupta M, Asakawa M, Suzuki T, Matsuda M, Fujii H, Rusyn I. Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma. Ann Surg Oncol 2007;14:1182-90.
9. Forton D, Karayiannis P. Established and emerging therapies for the treatment of viral hepatitis. Dig Dis 2006;24:160-73.
10. Levy C, Seeff LD, Lindor KD. Use of herbal supplements for chronic liver disease. Clin Gastroenterol Hepatol 2004;2:947-56.
11. Cohen MR. Herbal and complementary and alternative medicine therapies for liver disease. A focus on Chinese traditional medicine in hepatitis C virus. Clin Liver Dis 2001;5:461-78.
12. Oka H, Yamamoto S, Kuroki T, Harihara S, Marumo T, Kim SR, Monna T, Kobayashi K, Tango T. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer 1995;76:743-9.
13. Saiki I. A Kampo medicine "Juzen-taiho-to" - prevention of malignant progression and metastasis of tumor cells and the mechanism of action. Biol Pharm Bull 2000;23:677-88.
14. Saiki I, Yamaura T, Ohnishi Y, Hayakawa Y, Komatsu Y, Nunome S. HPLC analysis of juzen-taiho-to and its variant formulations and their antimetastatic efficacies. Chem Pharm Bull (Tokyo) 1999;47:1170-4.
15. Kamiyama H, Takano S, Ishikawa E, Tsuboi K, Matsumura A. Antiangiogenic and immunomodulatory effect of the herbal medicine "Juzen-taiho-to" on malignant glioma. Biol Pharm Bull 2005;28:2111-16.
16. Tatsuta M, Iishi H, Baba M, Nakaizumi A, Uehara H. Inhibition by shi-quan-da-bu-tang (TJ-48) of experimental hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats. Eur J Cancer 1994;30A:74-8.
17. Dhuley JN. Anti-oxidant effects of cinnamon (Cinnamomum verum) bark and greater cardamom (Amomum subulatum) seeds in rats fed high fat diet. Indian J Exp Biol 1999;37:238-42.
18. Keum YS, Park KK, Lee JM, Chun KS, Park JH, Lee SK, Kwon H, Surh YJ. Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng. Cancer Lett 2000;150:41-8.
19. Chino A, Sakurai H, Choo MK, Koizumi K, Shimada Y, Terasawa K, Saiki I. Juzentaihoto, a Kampo medicine, enhances IL-12 production by modulating Toll-like receptor 4 signaling pathways in murine peritoneal exudate macrophages. Int Immunopharmacol 2005;5:871-82.
20. Kawamata H, Ochiai H, Mantani N, Terasawa K. Enhanced expression of inducible nitric oxide synthase by Juzen-taiho-to in LPS-activated RAW264.7 cells, a murine macrophage cell line. Am J Chin Med 2000;28:217-26.
21. Friedman SL, Roll FJ. Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with. Stractan Anal Biochem 1987;161:207-18.
22. Peters JM, Rusyn I, Rose ML, Gonzalez FJ, Thurman RG. Peroxisome proliferator-activated receptor a is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis. Carcinogenesis 2000;21:823-6.
23. Trayner ID, Rayner AP, Freeman GE, Farzaneh F. Quantitative multi-well myeloid differentiation assay using dichlorodihydrofluorescein diacetate (H2DCF-DA) or dihydrorhodamine 123 (H2R123). J Immunol Methods 1995;186:275-84.
24. Clapp NK, Craig AW. Carcinogenic effects of diethylnitrosamine in RF mice. J Natl Cancer Inst 1967;39:903-16.
25. Ruebner BH, Gershwin ME, French SW, Meierhenry E, Dunn P, Hsieh LS. Mouse hepatic neoplasia: differences among strains and carcinogens. In: Popp JA, ed. Mouse liver neoplasia: current perspectives. Washington, DC: Hemisphere Publishing, 1984.115-44.
26. Maeda S, Kamata H, Luo JL, Leffert H, Karin M. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005;121:977-90.
27. Austyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981;11:805-15.
28. Okada S, Shimada K, Yamamoto J, Takayama T, Kosuge T, Yamasaki S, Sakamoto M, Hirohashi S. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 1994;106:1618-24.
29. Minagawa M, Makuuchi M, Takayama T, Kokudo N. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 2003;238:703-10.
30. Adachi E, Maeda T, Matsumata T, Shirabe K, Kinukawa N, Sugimachi K, Tsuneyoshi M. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 1995;108:768-75.
31. Chen YJ, Yeh SH, Chen JT, Wu CC, Hsu MT, Tsai SF, Chen PJ, Lin CH. Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology 2000;119:431-40.
32. Murakami T, Kim T, Nakamura H. Hepatitis, cirrhosis, and hepatoma. J Magn Reson Imaging 1998;8:346-58.
33. Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, Weinman SA. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002;122:366-75.
34. Korenaga M, Wang T, Li Y, Showalter LA, Chan T, Sun J, Weinman SA. Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem 2005;280:37481-8.
35. Miller ER, III, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005;142:37-46.
36. Kavanaugh CJ, Trumbo PR, Ellwood KC. The U.S. Food and Drug Administration's evidence-based review for qualified health claims: tomatoes, lycopene, and cancer. J Natl Cancer Inst 2007;99:1074-85.
37. Lee JS, Chu IS, Mikaelyan A, Calvisi DF, Heo J, Reddy JK, Thorgeirsson SS. Application of comparative functional genomics to identify best-fit mouse models to study human cancer. Nat Genet 2004;36:1306-11.
38. Teufelhofer O, Parzefall W, Kainzbauer E, Ferk F, Freiler C,Knasmuller S, Elbling L, Thurman R, Schulte-Hermann R. Superoxide generation from Kupffer cells contributes to hepatocarcinogenesis: studies on NADPH oxidase knockout mice. Carcinogenesis 2005;26:319-29.
39. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007;317:121-4.
40. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418:191-5.
41. Rose ML, Rusyn I, Bojes HK, Belyea J, Cattley RC, Thurman RG. Role of Kupffer cells and oxidants in signaling peroxisome proliferator-induced hepatocyte proliferation. Mutat Res 2000;448:179-92.
42. Shiota G, Maeta Y, Mukoyama T, Yanagidani A, Udagawa A, Oyama K, Yashima K, Kishimoto Y, Nakai Y, Miura T, Ito H, Murawaki Y, et al. Effects of Sho-Saiko-to on hepatocarcinogenesis and 8-hydroxy-2′-deoxyguanosine formation. Hepatology 2002;35:1125-33.
43. Imamichi T, Hayashi K, Nakamura T, Kaneko K, Koyama J. A Chinese traditional medicine, juzentaihoto, inhibits the O2-generation by macrophages. J Pharmacobiodyn 1989;12:693-9.
44. Lee YS, Han OK, Park CW, Yang CH, Jeon TW, Yoo WK, Kim SH, Kim HJ. Pro-inflammatory cytokine gene expression and nitric oxide regulation of aqueous extracted Astragali radix in RAW 264.7 macrophage cells. J Ethnopharmacol 2005;100:289-94.
45. Margalit M, Shibolet O, Klein A, Elinav E, Alper R, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y. Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes. Int J Cancer 2005;115:443-9.
46. Matsumoto T, Sakurai MH, Kiyohara H, Yamada H. Orally administered decoction of Kampo (Japanese herbal) medicine, "Juzen-Taiho-To" modulates cytokine secretion and induces NKT cells in mouse liver. Immunopharmacology 2000;46:149-61.